Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected …
この記事を読む
「論文メモ」の記事一覧 17ページ
この記事を読む
術後補助化学療法の維持療法；IMpower010
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a r…
この記事を読む
抗がん剤治療中でもCovid19ワクチンの効果は出るのか？
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Stud…
この記事を読む
エルロチニブ＋ラムシルマブ、EGFR遺伝子変異別のサブグループ解析
RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small C…
この記事を読む
EGFR-TKI耐性後の免疫治療 vs 殺細胞性抗がん剤
A Randomized Phase II Study Comparing Nivolumab with Carboplatin-Pemetrexed for EGFR-Mutated NSCLC with Resistance to EG…
この記事を読む
MET14skippingのテポチニブ治療は背景に依存するか
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION…
この記事を読む
SP142と22C3:同じか異なるのか
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell L…
この記事を読む
EGFR遺伝子変異陽性、切除後の予後は
Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II-IIIA (8th edition TNM…
この記事を読む
EGFR遺伝子変異陽性の術後補助化学療法の層別化
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small C…
この記事を読む
腫瘍サイズと免疫チェックポイント阻害薬
The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with …